Literature DB >> 18784371

CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses.

Ralf Geiben-Lynn1, John R Greenland, Kwesi Frimpong-Boateng, Nico van Rooijen, Avi-Hai Hovav, Norman L Letvin.   

Abstract

There is evidence that the limited immunogenicity of plasmid DNA vaccines is the result, at least in part, of the rapid clearance of vaccine antigen expression by antigen-specific immune responses. However, the cell types responsible for the clearance of plasmid DNA vaccine antigens are not known. Here we demonstrate that macrophages, NK cells, and CD8(+) T cells did not significantly contribute to the DNA antigen clearance but CD4(+) T cells played the crucial role in attenuating plasmid DNA vaccine antigen expression. Adoptive transfer experiments demonstrate that CD4(+) T cells facilitated DNA vaccine antigen clearance in a Fas/FasL-dependent manner. Furthermore, we show that depletion of CD4(+) T cells prevented the clearance of vaccine antigen and the appearance of a CD8(+) T-cell immune response. Inoculation of major histocompatibility complex class II KO mice with the plasmid DNA led to persistent antigen expression and abolition of a CD8(+) T-cell immune response. Importantly, the prolongation of antigen expression by disrupting the CD4(+) T-cell Fas/FasL myocytes signaling led to a 3- to 5-fold increase of antigen-specific CD8(+) T-cell responses. These data demonstrate a dominant role of CD4(+) T cell-mediated cytotoxicity in plasmid DNA vaccine antigen clearance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784371      PMCID: PMC2597129          DOI: 10.1182/blood-2008-06-165803

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Specific affinity fractionation of lymphocytes using glass or plastic bead columns.

Authors:  H Wigzell
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

2.  Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.

Authors:  T Stalder; S Hahn; P Erb
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

3.  The beige mutation in the mouse selectively impairs natural killer cell function.

Authors:  J Roder; A Duwe
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

4.  Granulocyte function in the Chediak-Higashi syndrome of mice.

Authors:  J I Gallin; J S Bujak; E Patten; S M Wolff
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

5.  Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon.

Authors:  S S Bao; N J King; C G dos Remedios
Journal:  Immunol Cell Biol       Date:  1990-08       Impact factor: 5.126

6.  Human myoblasts as antigen-presenting cells.

Authors:  N Goebels; D Michaelis; H Wekerle; R Hohlfeld
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

7.  CD8+ T lymphocytes are not required for murine resistance to human filarial parasites.

Authors:  T V Rajan; F K Nelson; L D Shultz; B H Koller; D L Greiner
Journal:  J Parasitol       Date:  1992-08       Impact factor: 1.276

8.  Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma.

Authors:  R Mantegazza; S M Hughes; D Mitchell; M Travis; H M Blau; L Steinman
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

9.  CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.

Authors:  F T Hakim; R T Gazzinelli; E Denkers; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

10.  Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

Authors:  Dan H Barouch; Maria G Pau; Jerome H H V Custers; Wouter Koudstaal; Stefan Kostense; Menzo J E Havenga; Diana M Truitt; Shawn M Sumida; Michael G Kishko; Janelle C Arthur; Birgit Korioth-Schmitz; Michael H Newberg; Darci A Gorgone; Michelle A Lifton; Dennis L Panicali; Gary J Nabel; Norman L Letvin; Jaap Goudsmit
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  16 in total

1.  PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer.

Authors:  Sai K Saridey; Li Liu; Joseph E Doherty; Aparna Kaja; Daniel L Galvan; Bradley S Fletcher; Matthew H Wilson
Journal:  Mol Ther       Date:  2009-10-06       Impact factor: 11.454

2.  Non-classical natural killer T cells modulate plasmid DNA vaccine antigen expression and vaccine-elicited immune responses by MCP-1 secretion after interaction with a beta2-microglobulin-independent CD1d.

Authors:  Ralf Geiben-Lynn; John R Greenland; Kwesi Frimpong-Boateng; Norman L Letvin
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

3.  Modulation of plasmid DNA vaccine antigen clearance by caspase 12 RNA interference potentiates vaccination.

Authors:  Ralf Geiben-Lynn; Kwesi Frimpong-Boateng; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2011-02-16

4.  Regulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbeta.

Authors:  Kwesi Frimpong-Boateng; Nico van Rooijen; Ralf Geiben-Lynn
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

5.  Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus.

Authors:  Bhawna Poonia; Maria S Salvato; Hideo Yagita; Toshihiro Maeda; Ko Okumura; C David Pauza
Journal:  Blood       Date:  2009-06-04       Impact factor: 22.113

6.  Mucosal application of gp140 encoding DNA polyplexes to different tissues results in altered immunological outcomes in mice.

Authors:  Jamie F S Mann; Paul F McKay; Samantha Arokiasamy; Reeyeshkumar K Patel; John S Tregoning; Robin J Shattock
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

7.  A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.

Authors:  David Hallengärd; Andreas Bråve; Maria Isaguliants; Pontus Blomberg; Jenny Enger; Richard Stout; Alan King; Britta Wahren
Journal:  Genet Vaccines Ther       Date:  2012-08-08

8.  Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscle.

Authors:  Maria C Subang; Rewas Fatah; Ying Wu; Drew Hannaman; Jason Rice; Claire F Evans; Yuti Chernajovsky; David Gould
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

9.  Immunization with an ApoB-100 Related Peptide Vaccine Attenuates Angiotensin-II Induced Hypertension and Renal Fibrosis in Mice.

Authors:  Tomoyuki Honjo; Kuang-Yuh Chyu; Paul C Dimayuga; Wai Man Lio; Juliana Yano; Portia Trinidad; Xiaoning Zhao; Jianchang Zhou; Bojan Cercek; Prediman K Shah
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

Review 10.  Role of the Fas/FasL pathway in HIV or SIV disease.

Authors:  Bhawna Poonia; C David Pauza; Maria S Salvato
Journal:  Retrovirology       Date:  2009-10-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.